CLDN6 promotes chemoresistance through GSTP1 in human breast cancer

[1]  Yuan Yuan,et al.  Expression of claudin-11, -23 in different gastric tissues and its relationship with the risk and prognosis of gastric cancer , 2017, PloS one.

[2]  B. Baradaran,et al.  Cancer chemoresistance; biochemical and molecular aspects: a brief overview. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[3]  Juan Chen,et al.  Sirtuin 3 enhanced drug sensitivity of human hepatoma cells through glutathione S-transferase pi 1/JNK signaling pathway , 2016, Oncotarget.

[4]  Xiangshu Jin,et al.  CLDN6-induced apoptosis via regulating ASK1-p38/JNK signaling in breast cancer MCF-7 cells. , 2016, International journal of oncology.

[5]  T. Oshima,et al.  Gastrointestinal mucosal barrier function and diseases , 2016, Journal of Gastroenterology.

[6]  Z. Zong,et al.  MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs , 2015, Drug design, development and therapy.

[7]  E. Leygue,et al.  Claudin 1 Promotes Migration and Increases Sensitivity to Tamoxifen and Anticancer Drugs in Luminal-like Human Breast Cancer Cells MCF7 , 2015, Cancer investigation.

[8]  P. Chakravarty,et al.  Glutathione S-transferase P1 (GSTP1) directly influences platinum drug chemosensitivity in ovarian tumour cell lines , 2014, British Journal of Cancer.

[9]  Xiang Ding,et al.  shRNA-mediated GSTP1 gene silencing enhances androgen-independent cell line DU145 chemosensitivity , 2014, International Urology and Nephrology.

[10]  Jun Lu,et al.  Establishment of paclitaxel-resistant breast cancer cell line and nude mice models, and underlying multidrug resistance mechanisms in vitro and in vivo. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[11]  J. Inazawa,et al.  Significance of GSTP1 for predicting the prognosis and chemotherapeutic efficacy in esophageal squamous cell carcinoma. , 2013, Oncology reports.

[12]  Jingjing Duan,et al.  Inhibition of P-glycoprotein and glutathione S-transferase-pi mediated resistance by fluoxetine in MCF-7/ADM cells. , 2013, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[13]  Z. Naito,et al.  Analysis of protein expression regulated by lumican in PANC‑1 cells using shotgun proteomics. , 2013, Oncology reports.

[14]  Liping Wang,et al.  Inhibition of p38 activity reverses claudin‐6 induced cell apoptosis, invasion, and migration , 2013, Chinese medical journal.

[15]  M. Zöller,et al.  EpCAM‐associated claudin‐7 supports lymphatic spread and drug resistance in rat pancreatic cancer , 2013, International journal of cancer.

[16]  M. Nitti,et al.  Role of Glutathione in Cancer Progression and Chemoresistance , 2013, Oxidative medicine and cellular longevity.

[17]  Q. Lu,et al.  Claudin‐7 increases chemosensitivity to cisplatin through the upregulation of caspase pathway in human NCI‐H522 lung cancer cells , 2013, Cancer science.

[18]  E. Asselin,et al.  Keratin 8 and 18 Loss in Epithelial Cancer Cells Increases Collective Cell Migration and Cisplatin Sensitivity through Claudin1 Up-regulation* , 2013, The Journal of Biological Chemistry.

[19]  S. Howell,et al.  Claudin-3 and Claudin-4 Regulate Sensitivity to Cisplatin by Controlling Expression of the Copper and Cisplatin Influx Transporter CTR1 , 2013, Molecular Pharmacology.

[20]  L. Luo,et al.  GSTP1 negatively regulates Stat3 activation in epidermal growth factor signaling , 2012, Oncology letters.

[21]  Carrie L. Griffiths,et al.  Triple Negative Breast Cancer: A Brief Review of its Characteristics and Treatment Options , 2012, Journal of pharmacy practice.

[22]  Shinzaburo Noguchi,et al.  GSTP1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER‐negative breast cancer , 2012, Cancer science.

[23]  A. Schenka,et al.  Glutathione S-transferase Pi expression in invasive breast cancer and its relation with the clinical outcome. , 2012, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[24]  Xueyan Dong,et al.  The expression patterns and correlations of claudin-6, methy-CpG binding protein 2, DNA methyltransferase 1, histone deacetylase 1, acetyl-histone H3 and acetyl-histone H4 and their clinicopathological significance in breast invasive ductal carcinomas , 2012, Diagnostic Pathology.

[25]  F. Casagrande,et al.  Eradication of chemotherapy‐resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of clostridium perfringens enterotoxin , 2011, Cancer.

[26]  Young-Ae Park,et al.  High claudin-7 expression is associated with a poor response to platinum-based chemotherapy in epithelial ovarian carcinoma. , 2011, European journal of cancer.

[27]  E. Laborde.  Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death , 2010, Cell Death and Differentiation.

[28]  G. Hortobagyi,et al.  Glutathione-S-Transferase-Pi Expression in Early Breast Cancer: Association With Outcome and Response to Chemotherapy , 2010, Cancer investigation.

[29]  P. Morin,et al.  The claudins , 2009, Genome Biology.

[30]  Jeffrey M. Rosen,et al.  Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features , 2009, Proceedings of the National Academy of Sciences.

[31]  Ye Zhang,et al.  GSTP1 determines cis-platinum cytotoxicity in gastric adenocarcinoma MGC803 cells: regulation by promoter methylation and extracellular regulated kinase signaling , 2009, Anti-cancer drugs.

[32]  Piero Picci,et al.  Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcoma. , 2008, Cancer research.

[33]  F. Ali-Osman,et al.  Identification and Functional Characterization of the Human Glutathione S-Transferase P1 Gene as a Novel Transcriptional Target of the p53 Tumor Suppressor Gene , 2008, Molecular Cancer Research.

[34]  Biaoyang Lin,et al.  Proteins Associated with Cisplatin Resistance in Ovarian Cancer Cells Identified by Quantitative Proteomic Technology and Integrated with mRNA Expression Levels*S , 2006, Molecular & Cellular Proteomics.

[35]  E. Siegel,et al.  Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin. , 2005, Cancer research.

[36]  S. Teramoto,et al.  GSTP1 affects chemoresistance against camptothecin in human lung adenocarcinoma cells. , 2004, Cancer letters.

[37]  Shijiang Lu,et al.  Identification of genes preferentially expressed in mammary epithelial cells of Copenhagen rat using subtractive hybridization and microarrays. , 2003, Carcinogenesis.

[38]  K. Tew,et al.  Glutathione S-transferase P1–1 (GSTP1–1) Inhibits c-Jun N-terminal Kinase (JNK1) Signaling through Interaction with the C Terminus* , 2001, The Journal of Biological Chemistry.

[39]  M. Kool,et al.  A family of drug transporters: the multidrug resistance-associated proteins. , 2000, Journal of the National Cancer Institute.

[40]  A. Tulpule,et al.  Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. , 1986, The Journal of biological chemistry.